Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lang

Showing results (761-770 of 809) with videos related to

Pageof 81
Sort By:
Heart (British Cardiac Society)|April 1, 2021
Telomere length is independently associated with all-cause mortality in chronic heart failureSimon P R Romaine, Matthew Denniff, Veryan Codd, et al.
Cardiovascular Research|March 8, 2023
Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failureGeorge Markousis-Mavrogenis, Waldemar B Minich, Ali A Al-Mubarak, et al.
European Journal of Heart Failure|November 13, 2019
Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatmentJan F Nauta, Yoran M Hummel, Jasper Tromp, et al.
International Journal of Cardiology|January 8, 2018
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failureJozine M Ter Maaten, Adriaan A Voors, Kevin Damman, et al.
European Journal of Heart Failure|April 4, 2020
A network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failureIziah E Sama, Rebecca J Woolley, Jan F Nauta, et al.
Nature Genetics|February 2, 2000
Aberrant CpG-island methylation has non-random and tumour-type-specific patternsJ F Costello, M C Frühwald, D J Smiraglia, et al.
Lancet (London, England)|August 27, 2019
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort studyBernadet T Santema, Wouter Ouwerkerk, Jasper Tromp, et al.
Clinical Proteomics|November 10, 2018
Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failureThong Huy Cao, Donald J L Jones, Paulene A Quinn, et al.
Acta Cardiologica|September 11, 2023
Effectiveness of out-patient based acute heart failure care: a pilot randomised controlled trialK Y K Wong, D A Hughes, M Debski, et al.
Acta Crystallographica. Section D, Biological Crystallography|September 27, 2006
Eukaryotic expression: developments for structural proteomicsA R Aricescu, R Assenberg, R M Bill, et al.
Pageof 81

Showing results (761-770 of 809) with videos related to

Sort By:
Pageof 81
Heart (British Cardiac Society)|April 1, 2021
Telomere length is independently associated with all-cause mortality in chronic heart failureSimon P R Romaine, Matthew Denniff, Veryan Codd, et al.
Cardiovascular Research|March 8, 2023
Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failureGeorge Markousis-Mavrogenis, Waldemar B Minich, Ali A Al-Mubarak, et al.
European Journal of Heart Failure|November 13, 2019
Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatmentJan F Nauta, Yoran M Hummel, Jasper Tromp, et al.
International Journal of Cardiology|January 8, 2018
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failureJozine M Ter Maaten, Adriaan A Voors, Kevin Damman, et al.
European Journal of Heart Failure|April 4, 2020
A network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failureIziah E Sama, Rebecca J Woolley, Jan F Nauta, et al.
Nature Genetics|February 2, 2000
Aberrant CpG-island methylation has non-random and tumour-type-specific patternsJ F Costello, M C Frühwald, D J Smiraglia, et al.
Lancet (London, England)|August 27, 2019
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort studyBernadet T Santema, Wouter Ouwerkerk, Jasper Tromp, et al.
Clinical Proteomics|November 10, 2018
Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failureThong Huy Cao, Donald J L Jones, Paulene A Quinn, et al.
Acta Cardiologica|September 11, 2023
Effectiveness of out-patient based acute heart failure care: a pilot randomised controlled trialK Y K Wong, D A Hughes, M Debski, et al.
Acta Crystallographica. Section D, Biological Crystallography|September 27, 2006
Eukaryotic expression: developments for structural proteomicsA R Aricescu, R Assenberg, R M Bill, et al.
Pageof 81